Compare HBCP & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HBCP | GEVO |
|---|---|---|
| Founded | 1908 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.2M | 470.1M |
| IPO Year | 2008 | 2011 |
| Metric | HBCP | GEVO |
|---|---|---|
| Price | $59.77 | $2.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $63.50 | $8.13 |
| AVG Volume (30 Days) | 21.1K | ★ 3.1M |
| Earning Date | 01-26-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ 24.56 | N/A |
| EPS | ★ 5.62 | N/A |
| Revenue | ★ $145,087,000.00 | $120,932,000.00 |
| Revenue This Year | $2.60 | $927.85 |
| Revenue Next Year | $3.27 | $12.01 |
| P/E Ratio | $10.47 | ★ N/A |
| Revenue Growth | 11.42 | ★ 675.75 |
| 52 Week Low | $39.59 | $0.92 |
| 52 Week High | $61.07 | $2.98 |
| Indicator | HBCP | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 75.06 | 55.60 |
| Support Level | $56.41 | $1.83 |
| Resistance Level | $57.31 | $2.42 |
| Average True Range (ATR) | 1.03 | 0.12 |
| MACD | 0.41 | 0.03 |
| Stochastic Oscillator | 94.23 | 71.19 |
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.